Does CytoSorb Interfere with Immunosuppression? A Pharmacokinetic and Functional Evaluation
Background/Objectives: Cytokine release during organ transplantation contributes to primary graft dysfunction and requires careful immunomodulation. CytoSorb, a hemoadsorption device developed to reduce circulating cytokine levels, is increasingly used ...
Claudia Schildböck +4 more
core +1 more source
Extracorporeal Blood Purification with CytoSorb® Hemoadsorption in Valve Surgery for Infective Endocarditis: A Case Series. [PDF]
Jonjev ŽS +4 more
europepmc +1 more source
ç©æ¥ç®¡çå¬å¸æåå®å¹æ¨¡å¼ä¹å»ºç«
æåä¹ç©æ¥ç®¡ç(Property Management, PM)å¬å¸ä¹ç¢åï¼ç©ç®¡æåçå質è广 ¼çºå½±é¿ç©ç®¡å¬å¸ç¶ç績æä¹ééµã檢è¦ç¾ä»ç©æ¥ç®¡çç¢æ¥ä¹æ¦æ³ï¼ç±æ¼åå°åå§æ³ä»¤ä¸å¥å¨åé²å¥é檻è¼ä½ä¹å½±é¿ï¼ä»¥è³æ¼ç©æ¥ç®¡çæ¥èèæ¼ååç«¶ççç°å¢ï¼é²èé ææ¥èéç«¶çåå¹å½±é¿å¶å質è婿½¤ãçºæ¤ï¼åå ...
è¡æä¿®
core
Hemoperfusion with CytoSorb® in Critically Ill COVID-19 Patients. [PDF]
Peng JY +5 more
europepmc +1 more source
Effects of CytoSorb<sup>®</sup> hemoadsorption therapy on serum myoglobin and creatine kinase levels in severe rhabdomyolysis: a systematic review and meta-analysis. [PDF]
Reynolds A +14 more
europepmc +1 more source
Mortality and adverse events of hemoadsorption with CytoSorb® in critically ill patients: A systematic review and meta-analysis of randomized controlled trials. [PDF]
Heymann M, Schorer R, Putzu A.
europepmc +1 more source
Hemadsorption with CytoSorb in Infants with Sepsis: Non-Systematic Review of Cases
Sepsis is a severe and potentially life-threatening condition that occurs when the body’s response to an infection damages its own tissues and organs. It can lead to organ failure and death if not treated. Cytosorb is a promising medical device for
Vitaliy Sazonov, Aruzhan Borankulova
core +1 more source
Hemoadsorption Using CytoSorb® in Patients with Infective Endocarditis: A German-Based Budget Impact Analysis. [PDF]
Rao C +7 more
europepmc +1 more source
Reply: Does adjunctive hemoadsorption with CytoSorb® affect survival of COVID-19 patients on ECMO? A critical statement. [PDF]
Putzu A, Schorer R.
europepmc +1 more source

